Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Disease Author: FDA Consumer Health Information Last Updated: Jul 7, 2016 - 5:36:25 PM

Irritable Bowel Syndrome Treatments Aren’t One-Size-Fits-All

By FDA Consumer Health Information
Apr 10, 2014 - 11:28:59 AM

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust

Email this article
 Printer friendly page

( - Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States. No one remedy works for all patients, so the Food and Drug Administration (FDA) is working to bring more treatments to the market

Read the Consumer Update to learn more.

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information" as the source. FDA values feedback on its consumer health information. Send questions, comments or story ideas to: [email protected].


For advertising or promotion on, call Mike McCurdy at: 877-634-9180. We have over 7,000 journalists as subscribers and may use our content


Top of Page

Latest Headlines

+ The Americas Celebrate 25 years Without Polio
+ Researchers Find Two Distinct Genetic Subtypes In Crohn’s Disease Patients
+ Coping With Crohn’s Disease
+ Brain Diseases Manifest in the Retina of the Eye
+ Region of the Americas is Declared Free of Measles
+ New Research Delimits the Possible Causes of Celiac Disease
+ Tattoo Therapy Could Ease Chronic Disease
+ Infectious Disease Transmission: It’s Who You Know and Where You Go
+ Common Bacteria Show Promise for Celiac Disease
+ The Importance of Catching and Treating Sepsis Early

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions